Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery - Wikidata - wikimedia - TriplyDB

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

http://www.wikidata.org/entity/Q35248656

about

Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide.The effect of non-specific tight junction modulators on the transepithelial transport of poorly permeable drugs across airway epithelial cells.

P2860

Q36144984-3B4993E0-06F1-4B37-9990-9C392916D942 Q51423431-E8192295-1854-4F9B-AD05-3C8378CA3324

P2860

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

http://www.wikidata.org/entity/Q35248656

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

@ast

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

@en

type

label

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

@ast

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

@en

prefLabel

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

@ast

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

@en

P1433

Q35248656-9C997A97-94A1-4529-8A03-60FC6EE4FE6A

P1476

Q35248656-01EAC6E1-8253-4421-A6DF-CD60681235F9

P2093

Q35248656-21B0E351-827D-4FCC-AB65-22AB73363283

Q35248656-3CEC4FE0-AF8B-4FB8-8FC5-022C92ABEEEB

Q35248656-52C6E25C-C806-4D1E-9099-8826DDCF3F22

Q35248656-53854DC3-7747-4B86-B411-A42F6D93789A

Q35248656-7083ABBB-6E5C-4139-A330-14BB5B5C9CFC

Q35248656-82D4B8E5-2233-413B-B608-A79E7A8A8200

Q35248656-8E3A12F7-0A21-4F84-A702-50768CC4D002

Q35248656-C92D6E95-214C-4B8B-A8D7-4BF3054B57AB

Q35248656-E4060887-C17C-4ECA-8B13-3F246D885412

P2860

Q35248656-01A1F568-1B38-48CF-AE6E-7F7ED3A3098C

Q35248656-355EE48C-5748-410B-9631-E167F4D39E91

Q35248656-3B375D77-9A1D-42DE-9C45-1FBF52EFAABC

Q35248656-447FCCBE-BD40-4E35-BD94-FA3699BA404A

Q35248656-492123BB-821C-46E3-81AA-7B3182877086

Q35248656-4D2F1B70-3B0F-46BD-BA48-6382497FA752

Q35248656-50ED59E4-F100-4B65-BD0D-F0FC1AB31533

Q35248656-7B3085E5-FB8B-4270-AEA9-287C5302D6C6

Q35248656-9F617E4C-39F4-4621-BD1E-525027F423B0

Q35248656-A35E3DC8-67F7-486C-91DA-354E9C61348C

P304

Q35248656-F94A99CE-4D54-4250-9BA3-09B434C9FB09

P31

Q35248656-71784C60-8C9D-4A7E-9564-6B2A13ECAD5F

P356

Q35248656-AAFFBCAB-C0B4-44B2-B345-A362CF56BFBA

P407

Q35248656-DB216ACF-EE5F-4AAB-A5BE-6ED0E941F308

P478

Q35248656-4E459ECC-AFC4-4718-B3D7-DDA56E56035A

P577

Q35248656-346D4C96-8029-4AC8-96FC-A7E5A33624E5

P5875

Q35248656-07A8A458-7AFB-48D2-B4D3-4722E9E669B7

P698

Q35248656-812804AE-80FC-4A48-947A-98A640099F49

P932

Q35248656-6A9BE8C1-6439-4FB3-B21D-EBD1D1DD6D32

P356

P1433

Drug Design, Development and Therapy

P1476

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

@en

P2093

Chang-Koo Shim

http://www.w3.org/2001/XMLSchema#string

Chul-Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Dae-Duk Kim

http://www.w3.org/2001/XMLSchema#string

Guang J Choi

http://www.w3.org/2001/XMLSchema#string

Keon-Hyoung Song

http://www.w3.org/2001/XMLSchema#string

Kiyoung Kim

http://www.w3.org/2001/XMLSchema#string

Sang-Bum Kim

http://www.w3.org/2001/XMLSchema#string

Sang-Ki Rhee

http://www.w3.org/2001/XMLSchema#string

Suk-Jae Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Instability, stabilization, and formulation of liquid protein pharmaceuticals.

Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.

Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro

Absorption enhancers for nasal drug delivery.

Stabilization of alpha-helical structures in short peptides via end capping

Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model.

Recent progress in tight junction modulation for improving bioavailability.

Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin.

Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin.

Effect of the biologically active fragment of zonula occludens toxin, delta G, on the intestinal paracellular transport and oral absorption of mannitol.

P304

1815-1823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S79383

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274644198

http://www.w3.org/2001/XMLSchema#string

P698

25848218

http://www.w3.org/2001/XMLSchema#string

P932

4383222

http://www.w3.org/2001/XMLSchema#string